IBL Healthcare has acquired 52,970 equity shares of India Home Health Care. Consequently, it has become a subsidiary company of IBL Healthcare.
The company has paid a consideration of Rs52.96 lakh.
Orthopedic care, cancer care, critical care, neuro care, tracheostomy and ventilator care, palliative care, geriatric care, postsurgical care, and wellness services are all available at IHHCPL.
IHHCPL is quickly becoming a reliable partner for leading Clinical Research Organizations (CRO) conducting Clinical Trials in the United States and Europe, having already made significant inroads into this segment under the brand name Avatar.
Avatar expects to generate approximately US$ 6 million in revenue over the next 36 months, up from the current run rate of US$ 500 thousand.
IHHCPL plans to open a state-of-the-art assisted living centre in March 2023, with a goal of expanding to 1000 units within the next 24 months.
At around 1.59 PM, Indrayani Biotech was trading at Rs87.75 up by 0.06% from its previous closing of Rs87.70 on the BSE. The scrip touched intraday high and low of Rs89.80 and Rs85 respectively.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.